Treatment focuses on preventing additional ... This deficiency affects the GCase enzyme and increases a patient's risk of ...

Conclusion: A patient with HIT developed severe skin necrosis after initiation of warfarin therapy. Warfarin is an integral component of heparin-induced thrombocytopenia (HIT) treatment.

In April 2008, certolizumab pegol (Cimzia; UCB), a tumour-necrosis factor blocker, was approved by the US FDA for the treatment of adult patients with moderate-to-severe Crohn's disease who have ...